Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug refers to the negative control formulation used in clinical trials sponsored by Colgate-Palmolive for the treatment of gingivitis and dental plaque. It is a sodium fluoride-based mouthwash containing 250 ppm of fluoride. In the context of these studies, it serves as a standard-of-care or non-antimicrobial comparator to evaluate the efficacy of experimental mouthrinses, such as the amine fluoride/zinc lactate system (meridol). Sodium fluoride primarily functions as an anti-caries agent by promoting the remineralization of tooth enamel and inhibiting demineralization, but it lacks the specific antimicrobial properties targeted for significant gingivitis reduction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sodium fluoride mouthwash 250 ppm.